Table 2.
Bromocriptine | No bromocriptine | P‐value | |
---|---|---|---|
(n = 8) | (n = 68) | ||
Medication at discharge, n (%) | |||
Beta‐blocker | 7 (88%) | 54 (82%) | 0.69 |
ACE‐inhibitor or angiotensin II receptor blocker | 7 (88%) | 56 (85%) | 0.84 |
Mineralocorticoid antagonist | 1 (13%) | 9 (14%) | 0.93 |
Hydralazine | 2 (25%) | 3 (5%) | 0.03 |
Nitrates | 0 (0%) | 1 (2%) | 0.73 |
Digitalis | 3 (38%) | 11 (17%) | 0.16 |
Furosemide | 4 (50%) | 43 (65%) | 0.40 |
Oral anticoagulant | 2 (25%) | 19 (29%) | 0.82 |
ACE, angiotensin‐converting enzyme.